comparemela.com

Latest Breaking News On - Health industry investment fund - Page 1 : comparemela.com

Healthcare-focused Vivo Capital closes new RMB fund at $1.4b

Vivo Capital closed the new RMB fund about 19 months after a first close at 4 billion yuan ($559.8 million) in May 2022.

California
United-states
Shanghai
China
Taipei
T-ai-pei
Taiwan
Palo-alto
Suzhou
Jiangsu
Beijing
Shan-fu

The remarkable results of strategic transformation of TOT, with a significant increase of 479% YoY in Operating Revenue, one-base, end-to-end ADC industrialization platform shows strong competitive

The remarkable results of strategic transformation of TOT, with a significant increase of 479% YoY in Operating Revenue, one-base, end-to-end ADC industrialization platform shows strong competitive
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong-kong
China
Suzhou
Jiangsu
Jixin
Hainan
Our-global-research
Stock-exchange-of-hong-kong
Development-center
Vivo-suzhou-fund
Jiangxi-jixin-pharmaceutical-co-ltd

TOT BIOPHARM Reached New Milestones in Interim -2-

DJ TOT BIOPHARM Reached New Milestones in Interim Results, with Sales Volume of over RMB 100 million, a Significantly Improved Capital Structure EQS Newswire / 15/08/2022 / 10:26 UTC+8 TOT BIOPHARM

China
Hong-kong
Jixin
Hainan
Tibet-autonomous-region
Xizang
Hebei
Jilin
Suzhou
Jiangsu
Macao
Macau-general

TOT BIOPHARM Reached New Milestones in Interim Results, with Sales Volume of over RMB 100 million, a Significantly Improved Capital Structure

DJ TOT BIOPHARM Reached New Milestones in Interim Results, with Sales Volume of over RMB 100 million, a Significantly Improved Capital Structure EQS Newswire / 15/08/2022 / 10:26 UTC+8 TOT BIOPHARM

China
Hong-kong
Jixin
Hainan
Tibet-autonomous-region
Xizang
Hebei
Jilin
Suzhou
Jiangsu
Macao
Macau-general

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.